glp-1 drugs overview Market Overview: Agonists and the Obesity Market | Blog GLP-1 Receptor Agonists and Research

Even minimal weight loss (1 kg) decreases the risk of heart failure in T2DM patients by 5.9% [90]

[DOI] [PubMed] [Google Scholar] 29.Srikanthan P, Karlamangla AS

Therefore, both these drugs can likely lead to the activation of the AMPK pathway and consequential proliferation of Tregs

1 For patients who do not achieve their target A1C with metformin, the Diabetes Canada 2018 guidelines recommend selecting add-on therapy based on individual patient characteristics

Is Toujeo safer than GLP-1 medications

Since elevated liver enzymes can be a concerning side effect for individuals taking GLP-1 receptor agonists, liver function should be monitored regularly